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Abstract 
Cancer is a progressive disease characterized by a biological disharmony in which damaged or  
 
mutated cells are able to survive and proliferate by escaping cell death. Moreover, these cells are  
 
reported to have elevated levels of reactive oxygen species (ROS) and are highly dependent on cellular  
 
defense mechanisms against oxidative stress. A specific cancer of the lymphatic system, lymphoma,  
 
affects our body’s infection-fighting cells while posing a great risk to all age groups. Numerous  
 
nutraceuticals and natural polyphenolic compounds have a wide range of abilities to alter cellular redox  
 
states with potential implications in various diseases. Furthermore, therapeutic options for cancers are  
 
mostly nonselective treatments including genotoxic or tubulin-targeting compounds. Some of the  
 
natural extracts, containing multiple bioactive compounds, could target multiple pathways in cancer  
 
cells to selectively induce cell death.  Cymbopogon citratus (lemongrass) and Camellia sinensis (white  
 
tea) extracts have been shown to have medicinal properties, however, their activity against lymphoma,  
 
as well as mechanistic details, have not been fully characterized. Herein, we report potent anti-cancer  
 
properties in dose and time-dependent manners of ethanolic lemongrass and hot water white tea  
 
extracts in lymphoma and leukemia models. Both extracts were able to effectively induce apoptosis  
 
selectively in these human cancer cell types. Interestingly, ethanolic lemongrass extract induces  
 
apoptosis primarily by the extrinsic pathway and was found to be dependent on the generation of ROS.  
 
Conversely, apoptotic induction by hot water white tea extract was independent of ROS. Furthermore,  
 
both of these extracts caused mitochondrial depolarization and decreased rates of oxygen consumption  
 
in lymphoma and leukemia cells, leading to cell death. Most importantly, both these extracts were  
 
effective in reducing tumor growth in human lymphoma xenograft models when administered orally.  
 
Thus, these natural extracts could have potential for being nontoxic alternatives for the treatment of  
 
cancer.  
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1.0  Chapter 1: Introduction 
 
 Cancer 
 
The term cancer encompasses a broad context used to characterize a spectrum of related diseases 
that fundamentally share abnormalities surrounding unregulated cell division. In result of this 
biological disharmony, damaged cells that would typically perish under normal conditions are 
alternatively able to survive and proliferate. Consequently, these erroneous cells ultimately favour 
aberrant growth of tissues or neoplasia otherwise known as tumors (National Cancer Institute, 2015). 
Due to the systemic nature of this disease, cancer creates an imbalance of the body’s homeostasis 
facilitated by evading regulatory mechanisms as the cancerous cells continue to replicate and acquire 
more mutations allowing them to proliferate while often bypassing growth suppression (Weinberg, 
1996). A particular set of oncogenes are frequently compromised leading to a loss-of-function thus 
encouraging active growth causing the cancer to thrive. In addition to the evasion of growth 
suppressors and sustained proliferation, cancer cells can be distinguished from non-cancerous cells by 
cell death resistance, induced angiogenesis, replicative immortality and achieving metastasis (Figure 1). 
Appropriately, this group of unique characteristics has been deemed the six hallmarks of cancer 
(Hanahan & Weinburg, 2000). Expanding from the list of six, additional characteristics have since 
emerged expanding into the realms of immunity avoidance and deregulation of cellular energetics. The 
homeostasis of the host is in time breached further leading to inflammation, malnutrition, 
immunosuppression and eventually death as the cancer metastasizes throughout the body (Hanahan & 
Weinberg, 2011).  
 
 
                     1 
2 
 
FIGURE 1 The Hallmarks of Cancer 
 
  (Hanahan & Weinberg, 2000) 
              
 
 
 
 
 
 
 
 
 
 
In 2016 an estimated 2 in 5 Canadians developed some form of cancer, while one year later the 
likelihood increased to 1 in 2 Canadians (Canadian Cancer Society, 2017). The prevalence of this 
disease is by no means contained to one region and has emerged to be a growing problem worldwide. 
More concerning is the number of new cancer cases which is expected to climb by roughly 70% over 
the following 2 decades as the population ages. Many contributing factors exist in support of the 
increasing number of cancer cases and include behavioural, environmental and dietary practices 
ranging from but not limited to smoking/alcohol, low vegetable intake, industry pollutants and 
increased exposure to direct sunlight (Danaei, 2005). Factors such as these positively correlate with 
the acquisition of mutations present in the onset and progression of most cancers. 
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 Existing Treatment 
 
Physical removal of cancerous tumors by means of surgery served as an initial means of 
treatment and remains viable today. Following surgery, radiation treatment became increasingly 
prevalent and served as a primary method in the induction of cell death amongst some cancer types 
either independently or in combination with the physical removal of a localized tumor (DeviTa Jr. & 
Rosenberg, 2012). Improved medical technology and diagnosis techniques have largely contributed to 
improving patient survival. However, many cancers continue to present challenges (Hanahan & 
Weinburg, 2000). Recently, research efforts have lead to the development of immunotherapy and 
antibody treatments capable of treating more challenging cancer types alongside anti-
VEGF/angiogenesis agents that limit blood supply to tumors (Roukos, 2009). Today’s conventional 
chemotherapeutics typically lead to serious side effects due to the nonselective nature of these 
treatments (systemic), targeting features common to both healthy and cancerous cells. An ideal 
treatment would possess the capacity to specifically target cancerous tissue by means of unique 
properties of their respective cellular pathways (Kamb, 2007). For example, Tamoxifen is a well-
known chemotherapeutic that acts as a selective estrogen receptor antagonist allowing the induction of 
cytostatic and pro-apoptotic mechanisms in estrogen receptor-positive breast cancers. Patients 
undergoing chemotherapeutic regimes experience difficulties coping with the toxicity of their 
treatments, and cancers may develop resistance to treatment hence limiting therapeutic potential as seen 
with the use of Tamoxifen (Wood, 2003).  The oxidative and mitochondrial vulnerabilities unique to 
cancer cells, such as their increased dependence on aerobic glycolysis to produce ATP rather than 
oxidative phosphorylation (Warburg effect), can be exploited (Vander Heiden, 2009). This process is 
thought to be initiated in part by mutations in mitochondrial DNA that shift oxidative phosphorylation 
while increasing electron leakage and facilitate the generation of reactive oxygen species (ROS) (Chen, 
2007) New approaches with selective therapies that circumvent the side effects of conventional 
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treatments can be developed, targeting the aforementioned vulnerabilities. Therefore, the difficulty in 
treating cancer is becoming less challenging, however identifying improvements continue to be a direct 
focus of the medical community.  
 Programmed Cell Death (PCD) 
 
Under typical conditions, the development and maintenance of living organisms depend on a 
highly regulated physiological process known as programmed cell death. Multicellular organisms are 
able to maintain homeostasis by riding itself of individual cells that may be damaged or present a 
hindrance to the overall integrity of the cell population (Elmore, 2007). Programmed cell death (PCD) 
exists in primarily two distinct categories. Apoptosis (PCD Type 1) is the most common form of 
programmed cell death whereas PCD Type II, otherwise known as Autophagy (Elmore, 2007), 
achieves a similar result.  An energy-independent cell death mechanism known as Necrosis results in 
response to external stimulus or injury in which cells advocate an inflammatory response confined to a 
localized area (Majno & Joris, 1995). Importantly in the case of cancer’s development and progression, 
cell death processes are manipulated as to avoid cell casualties and encourage proliferation while 
fostering resistance against anti-cancer drugs (Hanahan & Weinberg, 2011).  Coincidently cancers 
possess a tremendous capacity to either ignore or bypass cell suicide (or apoptosis) inducing signals 
thus allowing mutated tumorigenic cells to flourish. Therefore, when developing anti-cancer drugs, the 
primary focus is to exploit characteristics unique to cancer and establish selectivity in hopes of 
preventing apoptosis activation among normal cell populations. An attractive target often being a focus 
in cancer therapy is the mitochondria. Conveniently, tumorigenic cells possess not only fewer, but also 
morphologically different mitochondria which function to generate ATP and fuel a wide array of 
biochemical processes including cell death pathways (Hail, 2005). Interestingly, many proteins 
associated with the prevention of inducing apoptosis have been proven to be upregulated in some 
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cancers (Adams, 1998). An anti-apoptotic subclass of the Bcl-2 family which are typically localized to 
the outer membrane of mitochondria are found in higher concentrations in malignant environments 
(Adams, 1998).  These differences in mitochondria are significant as it can help create a selective 
foundation when planning treatments which can impede cancer’s strong capacity of escaping cell death.    
 Apoptosis 
 
Unique cellular morphological features can characterize cells that have undergone apoptosis. 
Such features include, nuclear and cytoplasmic condensation alongside the formation of membrane 
bound apoptotic bodies (Kerr, 1972). Moreover, phosphatidylserine (PS), which is typically located on 
the cytoplasmic side of the cell membrane, undergoes externalization, which in turn acts as a signal for 
the apoptotic cell to enhance elimination by phagocytes (Bratton, 1997).  This act of signaling can 
occur without an inflammatory response and spilling of cellular components into the cell’s cytosol as 
seen with necrosis (Proskuryakov, 2003). Apoptosis is a process that has previously been noted to 
occur in three general stages: an initiation phase involving a plethora of potential apoptosis inducing 
agents, secondly a decision phase in which the cell makes a “choice” to die or not die, and lastly a 
degradation phase generally involving the activation of caspase and nuclease proteins (Costantini, 
2000) which culminates in cell death by activating the apoptotic signaling cascade (Sinha Das, 
2013). Caspases belong to a family of cysteine-dependent aspartic proteases that exist inactively as 
preforms and activated via cleavage at aspartate residues. Once active, caspases are able to find 
numerous substrates within the cell that once undergo cleavage propel forward apoptotic processes 
(Fulda, 2006). Other potential mechanisms aside from caspase activation can initiate similar apoptotic 
events. In the case that apoptosis undergoes improper regulation, a lack of control can lead to array of 
disease including neurodegenerative diseases such as Alzheimer’s (Elmore, 2007). Oppositely, cells 
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that fail to receive the apoptotic signal evade cell death and can become tumorigenic as in the case of 
cancer mentioned prior.  
There are two major pathways of apoptosis, termed the intrinsic and extrinsic pathways (Figure 
2). A type of intracellular stress usually activates the intrinsic pathway. This causes the mitochondrial 
membrane pores to open, inducing mitochondrial membrane potential dissipation and the release of 
apoptogenic factors like endonuclease G, Smac/DIABLO, AIF and Omi/HtrA2, and cytochrome c 
(Earnshaw, 1999). Cytochrome c release leads to the activation of caspase-9, which in turn activates 
caspase-3 and yields the degradation of internal cellular structures and apoptosis execution (Figure 2). 
Observably with the intrinsic pathway of apoptosis, the mitochondrial  release of cytochrome c is 
instigated by pro-apoptotic members of the Bcl-2 family such as Bax, Bak Bad, Bcl-Xs, Bid, Bik, 
Bim, and Hrk (Ghobrial, 2005). These pro-apoptotic members are involved in regulating 
mitochondrial membrane potential (MMP). The release of cytochrome c from the mitochondria 
ultimately induces the recruitment of caspase -3 to the apoptosome, through the formation of 
the cytochrome c/Apaf-1/caspase-9-containing apoptosome complex (Fulda, 2006). Knowledge 
of these modes of cell death compel further research in the investigation of potential 
chemotherapeutics that may act as agents that could target these pathways in the cancer cell. 
Research in the area of natural health products (NHPs), which is the primary focus of this thesis and 
explained in more detail throughout the paper.  
By contrast, the extrinsic pathway is initiated through the interaction of a death receptor within 
the tumor necrosis factor (TNF) receptor superfamily which is composed of CD95 (APO-1/Fas) or 
TNF-related apoptosis-inducing ligand (TRAIL) receptors, which, upon binding, causes 
receptor trimerization and the subsequent recruitment of the adaptor protein with death domains (e.g. 
Fas-associated death domain, FADD) and the TNF related associated death domain TRADD, as 
well as the recruitment of the death domain pro-caspase-8 which together form the death 
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inducing signaling complex (DISC) (Fulda, 2006). The result of this is the cleavage and 
activation of caspase -8, which affects the cleavage of other downstream effector caspases which 
affects the cleavage of other downstream effector caspases such as caspase-3. Caspase-3 initiates 
further cleavage of substrates that further the progression of apoptosis (Fulda, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intrinsic Extrinsic 
    (Nimmanapalli & Bhalla, 2003) 
Figure 2: The Intrinsic and Extrinsic Pathways of Apoptosis 
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 Reactive Oxygen Species in Cancer 
 
Cancerous cells may use a differential pathway of metabolism; indeed, it has been reported that 
they generate higher amounts of reactive oxygen species (ROS). As a result of increased levels of ROS, 
various pro-survival mechanisms are elevated including proliferation and angiogenesis (Storz, 2005). 
Furthermore, they have upregulated anti-oxidative defense mechanisms, and an increase in the 
production of ROS can trigger apoptosis (Pignanelli, 2017). Interest in exploiting ROS to target cancer 
cells selectively/effectively has risen primarily since cancer cells already demonstrate higher levels of 
oxidative stress. Cancerous mitochondria have been shown to be selectively susceptible to certain 
compounds, further indicating that there are vulnerabilities unique to cancer cells (Ma, 2017). There are 
several processes that result in the formation of reactive oxygen species (ROS), as they are natural 
products of many cellular metabolic reactions. One such reaction is through oxidative phosphorylation 
during normal cell respiration. During normal cell respiration, where electrons are transferred down the 
electron transport chain (ETC), an improper reduction reaction of oxygen can occur such that a 
superoxide radical is formed instead of water. Usually this rare occurrence is corrected by cellular 
scavenger systems, however, when cell scavenger systems are overwhelmed, ROS levels become 
increasingly high. This imbalance of ROS and radical scavenging mechanisms is referred to as 
oxidative stress and can lead to severe damage and, in extreme cases, apoptosis (Schumacker, 2006). 
Often times, cytotoxic agents like chemotherapeutics, will either activate cell surface death receptors 
or will directly affect the mitochondria by disturbing its outer membrane integrity, causing an 
increase in ROS production. This oxidative stress in the mitochondria can cause cytochrome C to 
lose affinity  for the intermembrane space and be released into the cytoplasm through the mitochondrial 
permeability transition pore (MPTP) (Sinha, 2013). It is speculated that reactive oxygen species 
(ROS) play a role in the formation of the MPTP as ROS may cause the activation of BIM, which then 
induces the activation of the pro-apoptotic protein Bax. Subsequently, Bax interacts with the 
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mitochondria, causing the permeabilization of the outer mitochondrial matrix (Bustamante, 2005). 
In several cases, the combination of agents that increase ROS and those that suppress antioxidant 
defenses has been shown to be an effective treatment of different blood cancers with limited effects on 
normal lymphocytes (Bahlis, 2002; Kang, 2008; Zhou, 2003). This is of particular interest considering 
the scope of this thesis deals specifically with cancers of the lymphatic system. 
 Lymphoma 
 
Lymphoma is cancer that originates in the lymphatic system and affects infection-fighting cells 
otherwise known as lymphocytes. The lymphatic system expands throughout the body consisting of 
glands (lymph nodes) and several organs such as the thymus (Lymphoma Association, 2017). Due to 
its expansiveness, cancerous lymphocytes can originate almost anywhere and travel to many lengths 
of the body while collectively hindering healthy tissues and most importantly the immune system. 
Overall, there are more than 80 unique subtypes of mature lymphoid malignancy while lymphoma 
can further be divided into two separate categories, Hodgkin lymphoma (HL) and non-Hodgkin 
lymphoma (NHL) (Ansell, 2015). The more prevalent of the two cancer types is NHL representing 
8300 of 9290 total cases of lymphoma in Canada last year (CCS, 2017) Lymphomas, both Hodgkin’s 
and non-Hodgkin, are most commonly diagnosed in older adolescents and young adults, aged 15 – 29 
with 9290 new cases in Canada during 2017 (CCS, 2017). Even more alarming are the percentages 
surrounding lymphomas in children aged 0-14 which accounted for 11% of new cancer cases 
following only leukemia and cancers of the central nervous system (CCS, 2017).  
Non-Hodgkin lymphoma (NHL), are characterized by the distinct lack of Reed-Sternberg cells 
and are grouped based on which type of lymphocyte they originated from (Shankland, 2012). Most 
often, NHL starts from B-lymphocytes and to a lesser extent T-lymphocytes or natural killer cells. 
NHL will typically develop during B-lymphocyte maturation and activation, occurring in the bone 
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marrow and germinal center of the lymph nodes respectively. Both of these events involve DNA 
translocations and other modifications (Shankland, 2012) creating opportunity for DNA damage and 
mutations which favours cancer formation. NHL can also be caused by viral infections. Some viruses 
such as the Epstein-Barr virus are able to directly transform lymphocytes and lead to NHL’s like 
Burkitt’s lymphoma (Engels, 2007). HIV infections have also been shown to lead to NHL. 
Immunodeficiency caused by HIV creates the conditions for unregulated proliferation of B-
lymphocytes, which increases the likelihood of cancer formation. In general, some infections increase 
the risk of NHL development by inducing chronic immune stimulation. Long-term Hepatitis C 
infections can cause persistent activation of lymphocytes, leading to the development of NHL 
(Engels, 2007). 
Hodgkin lymphoma (HL) is a B-cell malignant neoplasm that represents 11% of all lymphomas 
and, in 2015, accounted for 9050 of new diagnosed cases of lymphoma (Siegel, 2015). As mentioned 
above, the critical difference between HL and NHL is that NHL is characterized by the distinct lack of 
Reed-Sternberg cells while HL contain these Red-Sternberg cells (Shankland, 2012). To establish a 
definitive diagnosis of Hodgkin lymphoma, Reed-Sternberg cells (large malignant multinucleated cells) 
within the biopsy specimen must be identified. Reed-Sternberg cells are commonly seen within a rich 
cellular environment composed of reactive lymphocytes, eosinophils, and histiocytes (Stein, 2001). 
Currently, the exact cause for development of HL has not been identified, but many factors have been 
suggested in scientific literature. Most notable criteria attributing to an increased risk for an individual 
to develop HL includes viral infection, familial factors, and immunosuppression (Ansell, 2015). The 
Epstein-Barr virus has been implicated to transform lymphocytes leading to HL development outside of 
the risk it presents to the causation of NHL. Immunocompromised individuals have been shown to have 
a higher risk for HL, additionally having a poorer prognosis due to HIV allowing for uncontrolled 
proliferation of lymphocytes, potentially leading to the development of cancer (Andrieu, 1993).  
11 
 
Although therapeutic advances have come a long way, there is a reoccurring need in understanding 
lymphoma pathogenesis and expediting new treatment that don’t pose significant risk especially to the 
younger populations who suffer from this disease. 
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 Natural Health Products and Active Compounds 
 
There is evidence presented by ancient human lineages that suggest the use of natural plant  
 
based products in the treatment of disease including cancer (Ji, Li, & Zhang, 2009). Though deemed  
 
as “scientific quackery” by some medical communities, Natural Health Products (NHPs) that have  
 
rich histories in traditional medicine (such as Ayurveda and Chinese medicine) provide a  
 
foundation of knowledge and reason for continued research and scientific validation. Two NHPs of  
 
interest that were explored further in the context of this thesis have shown particular medical value  
 
in research labs across the world and will be introduced in the following paragraphs. The complexity  
 
of phytochemical constituents found in the architecture of plants is often hypothesized to play a  
 
supporting role in ameliorating some disease conditions and/or symptoms. It must also be noted that  
 
these concentrations of bioactive compounds within many types of NHPs may be uniquely equipped  
 
to combat cancer and its multifaceted deregulation of numerous genes, which therefore may  
 
require a multi- targeted approach to treatment (Prasad, 2011). Phytochemical constituents elicit  
 
various physiological and/or pathological effects that could provide advantages in such a complex  
 
state of disease. Lastly, another advantage of   NHPs from a clinical standpoint is the low risk  
 
associated with human use and consumption over many years (Ji, 2009). For these reasons, NHPs  
 
continue to be recognized today with respect to significant efficacy and the ongoing search for  
 
novel safe chemotherapeutics with selective anti-cancer activity. Aside from the use of plant as their  
 
own entities, specific bioactive compounds found within plant material have contributed to the  
 
development or derivation of many available pharmaceutical agents including chemotherapy in  
 
the treatment of cancer (Foster, 2005) but exist in a wide range from analgesia all the way to  
 
medicines surrounding sedation. One of the major drawbacks of natural extract treatments is poor  
 
stability and bioavailability. The development of pharmaceutical agents from plant origin proves  
 
to be a beneficial way of bridging the gap between traditional and modern medicine. Two NHPs of  
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particular interest in which are also supported by both traditional and more recent targets of study are  
 
listed below. 
 
 
1.7.1 Lemongrass  
Cymbopogon citratus, more commonly known as lemongrass (LG), is an economically 
important perennial plant of the Poaceae family found in tropical environments or sub-tropical regions. 
The water (or aqueous) extract of lemongrass has been documented in traditional medicine showing 
efficacy in combatting fever, inflammation, digestive disorders and cancer (Thangam, 2014). 
Additionally, the aqueous extract of lemongrass has been found to be a potent free-radical scavenger 
(Halabi & Sheikh, 2014). Essential oil from lemongrass has various applications involving 
aromatherapy and includes uses in insecticides and pharmaceuticals. Published studies in the scientific 
literature including several review articles present a thorough breakdown of the phytochemistry 
belonging to stems, leaves, and even roots of the C. Citratus plant. Many of the biological effects 
ascribed to lemongrass have been attributed to primary constituents such as citral, 3,7-dimethyl-2,6-
octadienal, displaying anti-proliferative and anti-parasitic activity (Christopher, 2014). Most recently, 
citral containing lemongrass essential oils was shown to suppress the proliferation/survival of small-
cell lung cancer cells alone or in combination with chemotherapeutic agents (Takayuki, 2018). 
Interestingly, the results of our study evaluating anti-cancer activity of three compounds identified at 
higher concentrations in lemongrass (elemicin, lonicerin, and methylisoeugenol) showed very poor 
efficacy in reducing viability in lymphoma cells. Reasons supporting why this hypothesis may have 
failed are addressed in the discussion alongside possible solutions.  
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1.7.2 White Tea  
 
White tea (WT) is derived from the immature leaves of the Camellia sinensis belonging to the 
tea plant family Theaceae. Also found in this family are variations of green, black, and oolong tea - 
all of which display a wide array of health benefits based on different features in composition 
(Sereshti, 2013). Furthermore, this assortment of health promoting benefits have been observed to be 
in result of biological activities linked to an unique blend of polyphenols, volatile oils, vitamins and 
numerous other compounds found in prepared leaves of C. sinesis (Sereshti, 2013). Also important to 
note are the different levels of processing or harvested leaf development and how this correlates to 
distinctions in bioactivity. White tea being the least processed preparation is known to contain a 
distinct group of polyphenols specifically categorized as epicatechins, which are thought to directly 
support the positive assets attributed to white tea. Four major epicatechins include epicatechin, 
epicatechin-3-gallate, epigallocatechin, and epigallocatechin-3-gallate (Ravindranath, 2006) which 
are thought to be bioactive catechins able to interact with and quench ROS in vitro. As ROS have 
been linked to several progressive disease states, it is thought that the epicatechins in white tea can be 
used as a possible treatment. Currently, the anti-cancer and free radical scavenging properties of these 
compounds are being evaluated and addressed to an extent in body of this study. 
 Objectives 
 
Anecdotal evidence alongside existing scientifically validated studies, have shown that both 
lemongrass and white tea possess anti-cancer properties while exhibiting low or no toxicity at all. This 
thesis questions whether these same extracts possess significant anti-cancer properties against 
lymphoma cells lines primarily of the Non-Hodgkin’s lymphoma subtype. In addition, we set out to 
expand on further validating the mechanisms of action in which these extracts may or may not exploit 
cancer cells in hopes of hindering their ability to escape cell death and thus proliferate. We conducted 
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studies of both extracts as individual therapies alongside the exploration of possible synergistic 
activities in combination with each other. Our hypothesis is that the natural health products, LG & WT, 
contain various bioactive compounds in which can effectively target and exploit lymphoma cell 
vulnerabilities therefore acting as a selective alternative to current chemotherapies while exhibiting no 
toxicity.  In support of this hypothesis, there are three main objectives associated with this work:  
 
1. Assessing the cytotoxicity of LG and WT extracts (both aqueous and ethanolic) on lymphoma 
cell lines ex vivo as individual therapies and in combination.  
2. Investigating the mechanism of action and selectivity of LG & WT in lymphoma cell lines in 
contrast to normal healthy cells ex vivo.  
3. Evaluating the efficacy and toxicity of these extracts in a representative animal model 
(Lymphoma Xenograft Model in Immunocompromised Mice) 
 
 
2.0  Chapter 2: Materials & Methods 
 
 Lemongrass and White Tea Extraction 
 
The water and 100% ethanolic extracts of each plant were made from the stems of lemongrass 
and white tea leaves. The two plant products were purchased in an already pre-ground form from 
Premier Herbal (Toronto, Ontario, Canada) which is a wholesale supplier for various natural materials. 
The provided lot numbers for the lemongrass (grown in Guatemala) and white tea (grown in China) are 
315872 and WT1406KIT, respectively. 
 For the water extracts, before extracting, water was boiled (100°C) and then allowed to cool 
(until ~60°C). Each plant was then extracted with a 1:10 ratio of plant material (in grams) to distilled 
water (in mL) for three hours. The plant material was removed using cheesecloth, and the filtrate was 
centrifuged. The filtrate was then gravity-filtered using a P8 filter followed by vacuum filtration using a 
0.45 μm filter. Afterwards, the filtrate was then placed in a fridge at a temperature of -80°C overnight 
and freeze-dried. The extracted residue left behind was weighed and reconstituted to make 100 mg/mL 
stock solutions. 
 For the ethanolic extracts, each plant was extracted with a 1:10 ratio of plant material (in grams) 
to anhydrous ethanol (in mL). The solution was thoroughly mixed and allowed to extract for 
approximately 24 hours. Following extraction, the mixture was vacuum-filtered using a 0.2 μm filter, 
and the filtrate underwent rotary evaporation at a temperature of approximately 38-40°C. Now, with 
the ethanol evaporated, the weight of the dry resin was used to make a stock solution dissolved in 
anhydrous ethanol. The final concentration of the extract was 100 mg/mL. 
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 Cell Culture 
 
The MV-4-11 Chronic myelomonocitic leukemia cell line (ATCC, Cat. No. CRL-9591, 
Manassas, VA, USA) was cultured with Iscove's Modified Dulbecco's Medium (ATCC, Cat. No. 30-
2005, Manassas, VA, USA) supplemented with 10% (v/v) FBS standard (Thermo Scientific, Waltham, 
MA, USA) and 10 mg/mL gentamicin (Gibco BRL, VWR, Mississauga, ON, Canada). 
 
 The U-937 non-Hodgkin’s histiocytic lymphoma cell line (ATCC, Cat. No. CRL-1593.2, 
Manassas, VA, USA) was cultured with Iscove's Modified Dulbecco's Medium (ATCC, Cat. No. 30-
2005, Manassas, VA, USA) supplemented with 10% (v/v) FBS standard (Thermo Scientific, Waltham, 
MA, USA) and 10 mg/mL gentamicin (Gibco BRL, VWR, Mississauga, ON, Canada).   
 
The L-540 Hodgkin lymphoma (Leibniz-Institu DSMZ, Cat. No. ACC 72, Braunschweigh, 
Germany), was cultured with RPMI-1640 medium (Sigma-Aldrich Canada, Mississauga, ON, Canada) 
supplemented with 20% (v/v) fetal bovine serum (FBS) standard (Thermo Scientific, Waltham, MA, 
USA) and 10 mg/mL gentamicin (Gibco BRL, VWR, Mississauga, ON, Canada). 
 
The HD-MYZ Hodgkin lymphoma (Leibniz-Institu DSMZ, Cat. No. ACC 346, Braunschweigh, 
Germany), was cultured with RPMI-1640 medium (Sigma-Aldrich Canada, Mississauga, ON, Canada) 
supplemented with 10% (v/v) fetal bovine serum (FBS) standard (Thermo Scientific, Waltham, MA, 
USA) and 10 mg/mL gentamicin (Gibco BRL, VWR, Mississauga, ON, Canada). 
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The KM-H2 Hodgkin lymphoma (Leibniz-Institu DSMZ, Cat. No. ACC 8, Braunschweigh, 
Germany), was cultured with RPMI-1640 medium (Sigma-Aldrich Canada, Mississauga, ON, Canada) 
supplemented with 10% (v/v) fetal bovine serum (FBS) standard (Thermo Scientific, Waltham, MA, 
USA) and 
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 Isolation of Peripheral Blood Mononuclear Cells (PBMCs) 
 
All experiments involving human subjects (healthy volunteer donating blood) were done with 
prior approval of Research Ethics Board of the University of Windsor (protocol # REB #04-147), 
with informed consent obtained from the subject. Peripheral blood mononuclear cells (PBMCs) were 
isolated from a healthy volunteer in BD Vacutainer CPT Tubes with Sodium HeparinN (Becton, 
Dickinson and Company, Cat. No. 362753, Franklin Lakes, NJ, USA) at room temperature. Tubes 
were inverted 5 times and centrifuged for 30 minutes at room temperature at 1500-1800 x g. The 
PBMC layer under the plasma layer in each tube was collected, pooled together, resuspended in 50 
mL of PBS, and centrifuged at room temperature at 300 x g for 15 minutes.  The supernatant was 
aspirated without disturbing the pellet and PBMCs were suspended and cultured in RPMI-1640 
medium (Sigma-Aldrich Canada, Mississauga, ON, Canada), supplemented with 10%  (v/v) FBS 
standard (Thermo Scientific, Waltham, MA, USA) and 10 mg/mL gentamicin (Gibco BRL, VWR, 
Mississauga, ON, Canada) at 37 oC and at 5% CO2. PBMCs from healthy volunteers 1 (PBMCs V1) 
were taken from a healthy 28-year-old male. 
 
 WST-1 Assay for Cell Viability 
 
The WST-1 based colorimetric assay (Roche Applied Science, Indianapolis, IN, USA) was 
performed to quantify cell viability as a function of cellular metabolism. 96-well clear bottom tissue 
culture plates were seeded with cells. The cells were treated at the indicated concentrations and time 
points. The treated cells were incubated with WST-1 reagent for 4 hours at 37˚ C with 5 % CO2. In 
actively metabolizing cells, the WST-1 reagent is cleaved to formazan by cellular enzymes. The 
presence of formazan was quantified via absorbance readings at 450 nm on a Wallac Victor3 1420 
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Multilabel Counter (PerkinElmer, Woodbridge, ON, Canada). Cellular viability through measured 
absorbance readings expressed as percentages of the solvent control group.  
 Annexin V Binding Assay and Propidium Iodide (PI) for Analysis of Cell Death 
 
Annexin V binding assay and propidium iodide staining were performed to respectively monitor 
early apoptosis and cell permeabilization, a marker of necrotic or late apoptotic cell death. Cells were 
washed with phosphate buffer saline (PBS) and suspended in Annexin V binding buffer (10 mM 
HEPES, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4) with green fluorescent Annexin V AlexaFluor-488 
(1:20) (Life Technologies Inc, Cat. No. A13201, Burlington, ON, Canada) and 0.01mg/mL of red 
fluorescent PI (Life Technologies Inc, Cat. No. P3566, Burlington, ON, Canada) for 15 minutes at 37 
oC protected from light. Percentage of early (green), late apoptotic cells (green and red), and necrotic 
cells (red) were quantified with a Tali Image-Based Cytometer (Life Technologies Inc., Cat. No. 
T10796, Burlington, ON, Canada). Cells from at least 18 random fields were analyzed using both the 
green (ex. 458 nm; em. 525/20 nm) and red (ex. 530 nm; em. 585 nm) channels. Fluorescent 
micrographs were taken at 400x magnification using LAS AF6000 software with a Leica DMI6000 
fluorescent microscope (Wetzlar, Germany). Cells monitored with microscopy were counterstained 
with Hoechst 33342 (Molecular Probes, Eugene, OR, USA) with a final concentration of 10 μM during 
the 15-minute incubation. 
 Monitoring Mitochondria Membrane Potential 
 
Tetramethylrhodamine methyl ester (TMRM) (Gibco BRL, VWR, Mississauga, ON, Canada) 
was used for detecting mitochondrial membrane potential (MMP), an indicator of healthy intact 
mitochondria, Cells monitored with microscopy  were counterstained with Hoechst 33342 as 
previously described3 . Images were taken with a Leica DMI6000 fluorescent microscope (Wetlar, 
Germany) at 400x magnification using LAS AF6000 software. JC-1 was also utilized for 
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quantification of mitochondria membrane potential. Following treatment, JC-1 (Thermo Scientific, 
Cat. No. T3168, Waltham, MA, USA) at a concentration of 2 micromolar was added and allowed to 
incubate for 30 minutes. Following incubation, cells were washed twice in 1xPBS then analyzed 
using the Tali Image-Based Cytometer (Life Technologies Inc., Cat. No. T10796, Burlington, ON, 
Canada). Cells from at least 18 random fields were analyzed using the red (ex. 530 nm; em. 585 nm) 
channel. 
 Oxygen Consumption Quantitation 
 
Mitochondrial function was evaluated with the MitoXpress® Xtra - Oxygen Consumption Assay 
[HS Method] (Luxcel Biosciences Ltd., Cat. No. MX-200, Cork, Ireland). 1 000 000 cells/well were 
seeded in a 96-well black clear bottom tissue culture plate and incubated for an hour at 37˚ C and 5% 
CO2. On a heat pack, 10 μL of MitoXpress® reagent was added to each well excluding the blanks, cells 
were treated, the plate was shaken with a plate shaker, and 2 drops of pre-warmed high sensitivity 
mineral oil was added to each well to seal off the air supply. Bottom read fluorescence measurements 
were taken at Ex. 380 nm and Em. 650, every 2 minutes for 2 hours at 37 °C using a SpectraMax 
Gemini XS multi-well plate reader (Molecular Devices, Sunnyvale, CA, USA). Increases in 
fluorescence are indicative of oxygen consumption. Oxygen consumption rates were determined by  
calculating the slope of the linear regions of the oxygen consumption curves using GraphPad Prism 6 
software. 
 
 Quantitation of Reactive Oxygen Species (ROS) 
 
Whole cell ROS generation was monitored with the small molecule 2’, 7’-dicholorofluorescin 
diacetate (H2DCFDA). H2DCFDA enters the cell and is deacetylated by esterases and oxidized by ROS 
to the highly fluorescent 2’, 7’-dicholorofluorescein (DCF) (excitation 495 nm; emission 529 nm). 
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Cells were pretreated with 20 μM H2DCFDA (Sigma-Aldrich Canada, Cat. No. D6883, Mississauga, 
ON, Canada) for 30 minutes at 37°C protected from light at 5% CO2. Cells were treated for the 
indicated durations, centrifuged at 600 x g for 5 minutes and suspended in PBS. Percentage of DCF 
positive cells was quantified using the Tali Image-Based Cytometer (Life Technologies Inc., Cat. No. 
T10796, Burlington, ON, Canada) using 12 random fields per group with the green channel (excitation 
458 nm; emission 525/20 nm). 
 Xenograft Model (In Vivo) and Extract Administration 
 
All experiments involving animals (mice) and animal protocols were approved by the University 
of Windsor Animal Care Committee (AUPP # 14–15) in accordance with the Canadian Animal Care 
Committee. Immunocompromised CD-1 nu/nu male mice (Charles River Laboratories, Cat. No. 086, 
Sherbrooke, QC, Canada) were housed in laboratory conditions of a 12-hour light/dark cycle. Mice 
were injected using 23-gauge needles with 1 mL syringes with equal amounts of cell solution 
(containing 2x106 U-937 cells) and Corning Matrigel Basement Membrane Matrix (VWR International, 
Cat. No. 47743-715, Missisauga, ON, Canada) to a final volume of 200 microliters. Once tumors were 
established, the animals were randomized into three groups of 4 mice each including a control, 
treatment with LG, and treatment with WT. The control group was housed with a bottle of regular 
drinking water while the treatment groups were given water which contained the respective treatments. 
The water was changed regularly twice per week and the amount drank was measured. Each mice in 
the treatment groups was calculated to have consumed, on average, 80mg/kg/day of the respective 
treatment.   The volumes of the tumours were measured according to their length, width, and height 
twice per week and calculated using the ellipsoid formula п/6 × length × width × height. Changes in 
body mass were measured with a scale to assess for potential weight loss and determine whether 
treatments were well tolerated.  
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 Cell Lysis and Western Blot 
 
Preparation of cell lysates and Western blot analysis were performed as previously described 3. In 
brief, protein samples were run using SDS-PAGE and transferred to PVDF membranes. Membranes 
were blocked for one hour with either 5% skim milk or bovine serum albumin (BSA) at room 
temperature. Following blocking, the membranes were incubated with one of the following primary 
antibodies overnight at 4 °C: anti-caspase-8 antibody (1:1000) raised in mouse (Cell Signalling, Cat. 
No. 9746 S, Danvers, MA, USA), anti-caspase-9 antibody (1:1000) raised in rabbit (Cell Signalling, 
Cat. No. 9502, Danvers, MA, USA), anti-caspase-3 antibody (1:2000) (Novus Biologicals, Cat. No. 
NB100-56709V2, Littleton, CO, USA), anti-β-actin antibody (1:1000) (Santa Cruz Biotechnology, 
Inc., Cat. No. sc-81178, Paso Robles, CA, USA), anti-p-Histone H2A.X (Ser 139) (γ-H2AX) antibody 
(Santa Cruz Biotechnology, Inc., Cat. No. sc-101696, Paso Robles, CA, USA), and anti-vinculin 
antibody (1:2000) raised in rabbit (Cell Signalling, Cat. No. 13901, Danvers, MA, USA) 
 
 Cyrosectioning and Immunohistochemistry 
 
Following the in vivo study, U937 tumors were harvested and placed a 10% formaldehyde 
solution. Three days prior to sectioning, they were transferred to 30% sucrose (w/v). Tumors were then 
sectioned at 20µm and subjected to immunohistochemistry using either gamma H2AX (p Ser139) 
antibody (1:500) raised in rabbit (Novus Biologicals, Cat. No. NB100-384, Littleton, CO, USA), 
active/cleaved Caspase 8 antibody (1:500) raised in rabbit (Novus Biologicals, Cat. No. NB100-56116, 
Littleton, CO, USA), or anti-PCNA [pc10] antibody (1:400) raised in mouse (Abcam, Cat. No. ab29, 
Cambridge, MA, USA). Prior to overnight incubation with these primary antibodies at 4°C, the 
sections were incubated in 0.33% H2O2 for 2 minutes in order to block endogenous peroxidases, 
DAKO universal blocking solution (purchased from Diagnostics Canada Inc., Mississauga) for 30 
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minutes, and in normal goat serum (for primary antibodies raised in rabbit) or normal horse serum (for 
primary antibodies raised in mouse) for 30 minutes at room temperature (prepared as per instructions 
on anti-rabbit Vecstatin ABC Kit [Cat. No. PK-6101] or anti-mouse Vecstatin ABC Kit [Cat. No. PK-
6102], Vector Laboratories) in order to block the binding of non-specific goat or horse IgG. The 
sections were washed in Tris buffered saline (TBS) for 5 minutes in between each blocking step to 
remove any excess blocking reagents. Following the overnight incubation, the sections were washed in 
TBS twice and were incubated in biotinylated anti-rabbit IgG (Vector Laboratories, anti-rabbit 
Vecstatin ABC Kit [Cat. No. PK-6101]) or biotinylated anti-mouse IgG (Vector Laboratories, anti-
rabbit Vecstatin ABC Kit [Cat. No. PK-6102]) for 75 minutes at room temperature. The sections were 
then washed twice with TBS for 5 minutes and were incubated in avidin biotin complex (ABC reagent) 
for 45 minutes at room temperature. Following two additional TBS washes, the sections were subjected 
to the peroxidase substrate 3, 3′ diaminobenzidine (DAB) prepared as per the instructions in the kit 
(Vector Laboratories, DAB Peroxidase (HRP) Substrate Kit [Cat. No. SK-4100]). Sections were then 
counterstained with Hematoxylin Solution, Gill No. 1 (Sigma-Aldrich Canada, Cat. No. GHS116, 
Mississauga, ON, Canada) and washed twice in tap water for 5 minutes. The sections were then washed 
in Scott’s Bluing solution 5 minutes, followed by a 5-minute wash in TBS. The sections were then 
dehydrated in anhydrous ethanol and xylene and were cover-slipped using Permount for visualization 
under a microscope. 
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 Statistics 
 
Statistics from this study were performed with GraphPad Prism 6 statistical software. A p-value 
below 0.05 was considered significant. For the experiments with single variable measurements, which 
include quantification of MMP, and whole cell ROS, a One-Way ANOVA (nonparametric) was 
conducted and each sample's mean was compared to the mean of the negative control (DMSO vehcile) 
unless otherwise specified. For experiments that contained multi-variables (e.g. multiple group 
comparisions), such as the quantification of live and dead cells, Two-Way ANOVA (nonparametric) 
was used and each sample's mean was compared to the mean of the negative control (DMSO vehcile) 
unless otherwise specified. 
 
 Phytochemical Analysis 
 
The lemongrass extract LG072416 (10 mg) was  dissolved in 1 mL dimethyl sulfoxide (DMSO), 
and diluted with 50% methanol+50% water+0.1% formic acid to yield a final concentration of 10  
µ/mL. The diluted extract was  sonicated for 5 min  and filtered though  0.2µ  syringe filter. 
 
 Analytical Method 
 
Analysis was performed with an ultraperformance Liquid chromatograph connected with 
quadrupole time of flight mass spectrometer UPLC-QTOF (Waters Acquity Xevo G2 QTOF, Waters 
Corp. Separation was achieved with a  reverse phase column: Guard Filter, PN 289002378 + Acquity 
BEH C18 1.7um 2.1 x 50mm. The   mobile phase solvents were Fisher Optima LC-MS grade (Fisher 
Scientific, Ottawa ON), flow rate: 0.8 mL/min. The column temperature was 50  °C, and  autosampler: 
4 °C. Sample injection (PLUNO was  5uL, with a post injection needle wash: 200 uL (50% 
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acetonitrile+50% water) + weak wash 600 uL (10% acetonitrile+90% water). The mobile phase: A1: 
water+0.1% formic acid, B1: Acetonitrile+0.1% formic acid.  
The QTOF was used with the following conditions: sourcee 400 °C, cone gas (N2) flow 50 L/h, 
desolvation gas (N2) 1200 L/h, Cone voltage 35V, Scan time 0.08 sec. Calibration, 100-1500 Da. 
MassLynx software, MSe ESI+ mode. Enkephalin m/z556.2615 was used as a reference (ESI pos), 
source temperature 120 °C. Scans were  100-1500 Da, F1: CE, 6V, F2: CER 20-50V (both negative 
and positive ionization modes).  A 28 min step  gradient from A1:B1 = 99%:1% to 0%:100% was used.   
Compounds  were identified definitively based on in house spectral library  or tentatively based on 
monoisotipic mass observed in electrospray ionization on a QTOF within mass accuracy of 5 PPM.
 
 
3.0  Chapter 3: Results 
 
 Lemongrass and White Tea Extracts Reduce Viability of Lymphoma Cells 
 
Cold water (CW), hot water (HW), ethanolic-filtered (ETH-F), and ethanolic-unfiltered (ETH-
UF) extracts of lemongrass and white tea were prepared as described in the materials and methods. To 
evaluate the cytotoxicity of lemongrass and white tea extracts on various Hodgkin and non-Hodgkin’s 
lymphoma cell lines, the water-soluble tetrazolium-1 (WST-1) assay was utilized. Both lemongrass and 
white tea extracts reduced the viability of all the tested lymphoma cell lines in a dose-dependent 
manner (Fig. 1). In particular, the ETH-UF lemongrass and HW white tea extracts were the most 
effective. EC50 values for the different extracts and cell lines are available in Table 1. Interestingly, the 
non-Hodgkin’s lymphoma cell line, U-937, was sensitive to ETH-UF lemongrass extract at 
concentrations below 0.05 mg/mL whereas the Hodgkin’s lymphoma cell lines, KMH2, HDMYZ, and 
L540, were sensitive to ETH-UF lemongrass extract at concentrations below 0.1 mg/mL. Both the non-
Hodgkin’s and Hodgkin’s lymphoma cell lines displayed similar sensitivity to HW and CW white tea 
extracts. Thus, ETH-UF lemongrass extract and HW white tea extract were the main focus for further 
white tea extract were the main focus for further evaluation and characterization for this study. 
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Figure 3: Lemongrass and white tea extracts display broad efficacy in reducing cell viability in 4 
lymphoma cell lines. Cells were treated with various doses of lemongrass and white tea extracts 
prepared with cold water, hot water, unfiltered ethanol, and filtered ethanol for 48 hours. Following 
treatment, WST-1 cell proliferation assay was used and the absorbance at 450 nm was measured. Y-
axis is the percent mean ± SD from three independent experiments to the control and the x-axis is the 
concentrations used in milligram/ milliliter. Results graphed using the log(inhibitor) vs. response - 
Variable slope (four parameters) curve using GraphPrism6 
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 Induction of Apoptosis in Hodgkin and Non-Hodgkin’s Lymphoma Cells 
 
To assess the ability of lemongrass and white tea extracts to induce apoptosis in lymphoma cells, 
cells were stained with Annexin V and propidium iodide, general markers of apoptosis, and subjected 
to image-based cytometry and microscopy following treatment with the extracts. Following treatment 
for 48 hours, both lemongrass and white tea extracts were effective in inducing apoptosis in lymphoma 
cells (Fig. 4a). Notably, lemongrass extract was able to cause significant induction of apoptosis at a 
level (0.05 mg/mL) comparable to the standard chemotherapeutic VP16 in non-Hodgkin’s U-937 and 
Hodgkin’s KMH2 lymphoma cell lines. Fluorescent microscopy following treatment with lemongrass 
and white tea extracts and VP16 for 24 hours also revealed these cell death markers, along with 
apoptotic morphology in U-937 lymphoma cells, including cell shrinkage, membrane blebbing, and 
nuclear condensation (Fig. 4b). Most importantly, there was minimal to no observable apoptotic 
induction with normal human fibroblast cells at doses of lemongrass and white tea extracts that were 
highly cytotoxic to lymphoma cells after 48 hours comapred to the positive control staurosporin (STS) 
(Fig. 5a). Furthermore, in order to have a similar counterpart to lymphoma cells, we used peripheral 
nucleated blood cells (PNBCs) obtained from healthy individuals as a noncancerous control. These 
results further indicated that lemongrass extract showed minimal apoptotic effect on these cells, 
however white tea extract did induce apoptosis at higher doses (Fig. 5b). Therefore, lemongrass 
showed excellent selectivity to cancer cells whereas white tea extract was toxic to PNBCs at higher 
doses.  
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Figure 4: Lemongrass and white tea extracts induce apoptosis in several lymphoma cell lines; following 
treatment with specified doses, cells were stained for annexin V and PI. (A) Lymphoma cell lines tested at 48 
hours. Results were obtained using image-based cytometry with the Y-axis representative of percent of cells positive for 
Annexin V (green), PI (red), Annexin V and PI (yellow), or negative for both Annexin V and PI (blue). Values are 
expressed as a mean ± SD from three independent experiments. (B) U-937 micrographs at 24 hours. Top: Bright field and 
fluorescent merged images at 400x magnification. Bottom: Fluorescent images stained with Annexin V (green), PI (red), 
and Hoechst (blue) at 400× magnification. Scale bar is 50 microns. Images are representative of three independent 
experiments. Values are expressed as a mean ± SD from three independent experiments. Statistical calculations were 
performed using Two-Way ANOVA multiple comparison. *p < 0.05 vs. Control, **p < 0.01 vs. Control, ****p < 0.0001 vs. 
Control 
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Figure 5: Lemongrass and White Tea Extracts Do Not Induce Apoptosis in Non-Cancerous Cells – (A) Normal human skin fibroblasts 
and (B) peripheral blood nuclear cells (from healthy individuals) were tested at 48 hours. Following treatment with speciied doses, cells 
were stained for Annexin V and PI. Results were obtained using image-based cytometry with the Y-axis representative of percent of cells 
positive for Annexin V (green), PI (red), Annexin V and PI (yellow), or negative for both Annexin V and PI (blue). Values are expressed as 
a mean ± SD from three independent experiments. Statistical calculations were performed using Two-Way ANOVA multiple comparison. 
p < 0.0001 vs.Control. 
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 Mitochondrial Depolarization and Reduced Oxygen Consumption  
 
Mitochondria play a key role in apoptosis, which can be triggered by mitochondrial dysfunction. 
This can lead to the permeabilization of the mitochondrial membrane, the release of apoptogenic 
factors, and the induction of apoptosis4. To monitor mitochondrial stability and depolarization, the 
fluorescent JC-1 assay was used. At time points as early as six and 12 hours, lemongrass and white 
extracts were able to decrease the percentage of cells positive for the JC-1 dye, and increasingly drastic 
reductions were observed at the 24 and 48 hour time-point (Fig. 6a). This result indicates the collapse 
of mitochondrial potential in cells treated with lemongrass and white tea extracts.  
To further investigate mitochondrial function directly, following treatment with lemongrass and 
white tea extracts, oxygen consumption was evaluated as described in materials and methods. 
Lemongrass and white tea extracts significantly decreased the rate of oxygen consumption in non-
Hodgkin’s U-937 lymphoma cells (Fig. 6b). Antimycin A (AMA) inhibits complex III of the ETC, and 
so it was used as a positive control in evaluating the disruption of oxygen consumption. This finding 
indicates that lemongrass and white tea extracts effectively decrease oxygen consumption and, 
therefore, mitochondrial function. 
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Figure 6: Lemongrass and white tea extracts cause mitochondrial depolarization and decreased rates of 
oxygen consumption in lymphoma cells. (A) Lymphoma cells were plated and allowed to incubate overnight. 
Following overnight incubation, cells were treated for 6, 12, 24, and 48 hours. To monitor mitochondria potential cells were 
incubated with JC-1 for 30 minutes before analysis. Results were obtained using image-based cytometry with the Y-axis 
representative of percent of cells positive for JC-1 expressed as a mean ± SD from three independent experiments. (B) The 
MitoXpress® Xtra - Oxygen Consumption Assay was used to monitor oxygen consumption via fluorescence generation as 
an indicator of mitochondrial function. U-937 lymphoma cells were treated with white tea extract (WT), lemongrass extract 
(LG), and antimycin A (AMA), and the fluorescent MitoXpress® reagent was added monitored at Ex. 380 nm and Em. 650, 
every 2 minutes for 2 hours at 37°C. Oxygen consumption rates were calculated by measuring the slopes of the linear 
regions of the oxygen consumption curves. Values are expressed as mean ± SD from at least 3 independent experiments. *p 
< 0.05 vs. Control, **p < 0.01 vs. Control, ***p < 0.001 vs. Control, ****p < 0.0001 vs. Cont 
35 
 
 Oxidative Stress Dependence of Lemongrass Extract to Induce Apoptosis 
 
Further investigating the mechanism of induction of apoptosis by these extracts, we observed that 
lemongrass extract induced production of ROS in several blood cancer cell lines, such as non-
Hodgkin’s lymphoma U-937 cells and E6-1 Jurkat cells, as indicated by an increase in percent of cells 
positive for DCF, similar to the positive control piperlongumine (PL) (Fig. 7a). In contrast, white tea 
extract showed minimal to no increase of ROS production in these cell lines (Fig. 7a). We wanted to 
investigate if this increase in oxidative stress is essential in the downstream effects of lemongrass 
extract for the induction of apoptosis. When pre-treated with the potent antioxidant N-acetyl cysteine 
(NAC), there was a near complete inhibition of markers for apoptosis and mitochondrial destabilization 
across numerous cancerous cell lines following treatment with lemongrass extract, similar to the 
positive control paraquat (PQ). The markers for apoptosis were however unaffected following 
treatment with white tea extract (Fig. 7b). Further experimentation with lemongrass extract 
investigated the role of oxidative stress in mitochondrial destabilization after treatment of three blood 
cancer cell lines (MV-4-11, E6-1, U-937) with lemongrass extracts and NAC, as indicated by a 
decrease in percent cells positive for JC-1 relative to the control (Fig. 7c). When pre-treated with NAC, 
leukemia cells showed stabilized mitochondrial membrane potential in a qualitative microscopy study 
as indicated by the presence of red JC-1 dye around the blue Hoechst-stained DNA (Fig. 7d). 
Furthermore, these results are complemented by the reduction in cleavage of caspase-8 and -9 by NAC 
co-treatment (Fig. 7e). These results indicate that lemongrass and white extracts induce cell death by 
different mechanistic pathways; lemongrass extract appears to be dependent on oxidative stress for the 
induction of apoptosis whereas white tea extract is independent of oxidative stress. 
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Figure 7: Lemongrass extract is dependent on the production of oxidative stress to induce apoptosis. (A) MV-4-11, 
E6-1, and U-937 cells were treated with piperlongumine (PL), LG, or WT with or without the antioxidant NAC for 48 
hours. Following treatment, cells were stained for Annexin V and PI. Results were obtained using image-based cytometry 
with the Y-axis representative of percent of cells positive for Annexin V (green), PI (red), Annexin V and PI (yellow), or 
negative for both Annexin V and PI (blue). Values are expressed as a mean ± SD from three independent experiments. (B) 
U-937 and E6-1 cells were treated with H2DCFDA following treatments with paraquat (PQ), LG, or WT with or without 
the antioxidant NAC for 3 hours. Results were obtained using the image-based cytometry with the Y-axis representative of 
percent of cells positive for DCF. Values are expressed as a mean ± SD from three independent experiments. (C) MV-4-11, 
E6-1, and U-937 cells were plated and allowed to incubate overnight. Following overnight incubation, cells were treated for 
48 hours with or without NAC. To monitor mitochondria potential cells were incubated with JC-1 for 30 minutes before 
analysis. Results were obtained using image-based cytometry with the Y-axis representative of percent of cells positive for 
JC-1 expressed as a mean ± SD from three independent experiments. (D) U-937 micrographs at 48 hours. Top: Fluorescent 
images of cells without NAC stained with JC-1 (red) and Hoechst (blue) at 400x magnification. Bottom: Fluorescent images 
of cells with NAC stained with JC-1 (red) and Hoechst (blue) at 400x magnification. Scale bar is 25 microns. Images are 
representative of three independent experiments. (E) E6-1 cells were treated for 3 hours with LG with or without NAC, 
lysed, and subjected to SDS-PAGE. Cells were then transferred to a PVDF membrane and probed for the specific proteins. 
Bands were visualized with a chemiluminescence reagent. Statistical calculations were performed using Two-Way ANOVA 
multiple comparison for (A) and One-Way ANOVA multiple comparison for (B–C). **p < 0.01 vs. Control, ****p < 
0.0001 vs. Control 
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 FADD Protein Involvement in Cancer Cells Treated with Lemongrass Extract 
 
In order to investigate the role of specific death pathways, we probed for caspase activation in 
non-Hodgkin’s U-937 lymphoma cells and E6-1 Jurkat cells lacking a functional Fas-associated protein 
with Death Domain (dnFADD Jurkat). Western blot analysis indicated that treatment with lemongrass 
extract activated caspase-8 in both cell lines, but caspase-3 was only activated in U-937 cells (Fig. 8a, 
7b). As a result, cell death by lemongrass extract was inhibited in the dnFADD cells (Fig. 8c). 
Contrastingly, white tea extract maintained its ability to induce apoptosis in the dnFADD cell line and 
without caspase-3 activation (Fig. 8b, 6c). Interestingly, lemongrass extract maintained its ability to 
produce ROS and white tea extract continued to show no increase in ROS production in the dnFADD 
cells (Fig. 8d). These results indicate that lemongrass extract requires a functioning FADD protein for 
its apoptotic activity whereas white tea extract exhibits apoptotic activity independent of the FADD 
protein, and further corroborate the hypothesis that lemongrass and white tea extract induce cell death 
by different mechanistic pathways. 
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Figure 8: Functioning FADD protein is required to induce apoptosis in cancer cells treated with 
lemongrass extract. (A) U-937 and (B) DN FADD Jurkat cells were treated for 12 hours and 48 hours, 
respectively, with the specified treatments, lysed, and subjected to SDS-PAGE. Cells were then transferred to a 
PVDF membrane and probed for the specific proteins. Bands were visualized with a chemiluminescence reagent. 
(C) DN FADD Jurkat cells were treated for 48 hours with the specified doses and stained with Annexin V and 
PI. Results were obtained using image-based cytometry with the Y-axis representative of percent of cells 
positive for Annexin V (green), PI (red), Annexin V and PI (yellow), or negative for both Annexin V and PI 
(blue). Values are expressed as a mean ± SD from three independent experiments. (D) DN FADD Jurkat cells 
were treated with H2DCFDA following treatments with paraquat (PQ), LG, or WT for 3 hours. Results were 
obtained using the image-based cytometry with the Y-axis representative of percent of cells positive for DCF. 
Values are expressed as a mean ± SD from three independent experiments. Statistical calculations were 
performed using Two-Way ANOVA multiple comparison for (C) and One-Way ANOVA multiple comparison 
for (D). ***p < 0.001 vs. Control, ****p < 0.0001 vs. Control 
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 Lemongrass and White Tea Extracts Reduce Tumor Size in Lymphoma 
Xenograpft Model in Immunocompromised Mice  
 
Having seen effective induction of cell death by lemongrass and white tea extracts in several cell 
lines, we wanted to evaluate if this compound has the ability to inhibit growth of histiocytic lymphoma 
xenografts in mice. U-937 cells were transplanted subcutaneously in immunocompromised mice as 
described in the materials and methods. After palpable tumors were established, each treatment group 
was orally administered with either lemongrass or white tea extracts via supplemented drinking water 
over the course of three weeks. Both extracts were able to decrease the growth of the xenograft as 
determined by tumor volume relative to the vehicle control (Fig. 9a, 9b). Over the three-week study, 
there was no apparent change in body weight of mice in each group compared to the control, indicating 
that the animals were able to tolerate the administered treatments (Fig. 9b). Furthermore, 
immunohistochemical staining was performed for tumor tissues treated by both lemongrass and white 
tea extracts. There was an increase in γ-H2AX phosphorylation, an indicator of DNA breaks, as well as 
a reduction in positive staining for PCNA, a marker for cellular proliferation, in both the lemongrass 
and the white tea extract-treated groups compared to the control group in the tumor sections (Fig. 9c). 
Thus, these findings illustrate that lemongrass and white tea extracts are effective in reducing tumor 
growth in vivo when administered orally. 
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Figure 9: Orally administered lemongrass and white tea extract reduce tumor size in lymphoma xenograft 
model in immunocompromised mice. Immunocompromised mice were subcutaneously injected with cancerous cells 
and tumors were allowed to establish. Treatments occurred every other day and the studied compound or the equivalent 
vehicle control administered orally for three weeks. (A, B) The tumors were photographed before and after extraction from 
the animals. (C) Tumor volume and mass were measured two times per week. (D) Immunohistochemistry analysis of 
sectioned tumor tissues from the lymphoma study. Each section was subjected to the specified antibody followed by a 
biotinylated secondary antibody. Detection was done using a DAB Peroxidase HRP Substrate Kit (brown) followed by 
Hematoxylin counterstaining (purple). Images were obtained using inverted bright field microscopy. Sectioning results are 
representative of three individual tumors. Scale bar is 50 microns. Statistical analysis using One-Way Anova. *p<0.05 vs 
tumour volume of the control. 
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 Phytochemical Analysis of Ethanolic Lemongrass Extract  
 
As shown in the results above, since the unfiltered, ethanolic lemongrass extract has the most 
effective and selective anti-cancer activity, we performed a phytochemical analysis of this particular 
extract. Commonly occurring compounds (34 in all) were selected for detection based on published 
literature searched with the key word Cymbopogon.  Elimicin and lonicerin were identified based on a 
spectral library of over 900 phytochemicals, which we have recorded in UNIFI software (Table 2). 
Methyl isoeugenol was putatively identified based on monoisotopic mass observed in electrospray 
ionization on a Q-TOF within mass accuracy of 5 PPM and compared to published literature. Spectra 
of an additional 283 phenolic compounds in our in-house library of standards were matched with the 
spectra obtained in positive and negative modes. Commonly known phenolics were not present in the 
extract.  
Three compounds in the extract (elemicin, lonicerin, and methylisoeugenol) were identified in 
addition to the existing phytochemicals in the spectral library. These compounds were evaluated for 
their anti-cancer activity, both alone and in combination, as these were hypothesized to potentially be 
the active compounds contributing to the anti-cancer activity of lemongrass extract. However, our 
results show very poor anti-cancer activity, if at all, at very high doses (Fig. 10). Further work with 
other phytochemical classes will be required with purification of each compound and activity analysis.  
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Figure 10: Cytotoxic activity of three compounds identified in lemongrass extract individually  
                   and in combination on a lymphoma cell line. 
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Table 2: Three unique compounds identified in lemongrass extract 
 
Compound Molecular 
formula 
Monoisotopic Mass Calculated [M+H]+ Observed 
[M+H]+ 
Calculated [M-
H]- 
Retention time 
(min) 
 
Comments  
Elemicin C12H16O3 208.1099 209.1178 (1+) 209.1150 207.1021 (1–) 3.00 Reported in 
Cymbopogon 
procerus 
 
Lonicerin C27H30O15 594.1585 595.1663 (1+)                593.1506    
      (1–) 
              3.54      Cymbopogon      
     Citratus 
 
Methylisoeugenol C11H14O2 178.0994 179.1072 (1+) 179.1050 177.0916 (1–) 2.43 Edited by Jiangsu 
New Medicinal 
College, Chinese 
Medicine 
Dictionary, 
Shanghai Science 
and technology 
Press, Shanghai, 
(1979)Sun, et al., 
Brief Handbook 
of Natural Active 
Compounds, 
Medicinal 
Science and 
Technology Press 
of China, Beijing, 
(1998) 
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4.0   Chapter 4: Discussion 
 
 Evaluation of Natural Health Product (NHP) Extracts 
 
The primary aim of this project began with the evaluation of various NHPs that have 
established a level of medical promise in existing scientific literature or accompanied by strong 
anecdotal evidence. More specifically for the purpose of this study, NHP extracts (aqueous and 
ethanolic) were screened as potential non-toxic alternatives for lymphoma treatment either as 
individual treatments or in combination. Important to note is the concept of using only water and 
ethanolic extraction protocols for the purpose of this study. In communities of natural health and 
NHP development, both aqueous and ethanolic extracts are recognized to be two most accepted 
biocompatible solvents and were the only extraction protocols used for this study. Exploring different 
extraction methods such as Supercritical Fluid Extraction (SFE) may be an area of future interest 
amongst other research groups.  In total, we tested 28 extracts from different plant materials (used 
traditionally in various cultures) and found that two extracts were among the few that showed the 
most significant anti-cancer activity against human lymphoma cells at reasonably low concentrations. 
Although lemongrass and white tea were chosen for the purpose of this thesis, other lab members 
further studied some honourable mentions including Hibiscus, Siberian Ginseng and Sage extracts. 
Due to the complex composition of NHPs, a lot of work was done in depicting accurate conclusions 
surrounding   efficacy, mechanisms, and selectivity in order to measure and properly validate each 
respective extract as safe alternatives to other current lymphoma treatments. 
 
 
 
45 
 
 Anti-Cancer Efficacy and Selectivity of Lemongrass and White Tea Extracts 
 
4.2.1 Effect on Viability in Lymphoma Cells 
 
To assess the efficacy of LG and WT we began with a cell viability assay, WST-1, by following 
a standard protocol in measuring the respective ability of these two extract in impeding cell 
metabolism of 4 lymphoma cell lines. Although the results aren’t shown in this paper, a trypan blue 
assay was carried out in support of the cell viability assayEthanolic, unfiltered (ETH-UF) lemongrass 
(LG) extract in particular had the greatest cytotoxic properties on these cancers compared to the other 
extraction methods (cold water, hot water and filtered, ethanolic) with EC50 values well below 
0.08mg/mL for all four commercially available lymphoma cell lines while the cold and hot water 
extractions (CW and HW) for white tea (WT) appeared to be slightly more effective compared to 
their ethanolic counterparts with EC50 values below 0.2mg/mL. These results illustrate how the 
extraction procedure is an important factor to consider when examining the use of plant extracts for 
the purpose of developing disease therapies. Furthermore, this would also imply that the yield of 
different bioactive molecules are extraction-method dependent and ultimately affect the resultant 
potency of each extract, a phenomenon observed previously in literature (Gil-Chávez, 2013) Such 
molecules could be specific primary (e.g. amino acids, fatty acids, sugars) or secondary (e.g. 
carotenoids, terpenoids, alkaloids) metabolites, which may be acquired or lost through the type of 
solvent used for extraction (water or ethanol) and if the extract is filtered or not. Only ETH-UF-LG 
and HW-WT were studied further as they were found to be the most efficacious of the four different 
extracts.  
4.2.2 Destabilization of Mitochondrial Membrane Potential and Induction of PCD in Lymphoma Cells 
 
Moving forward with the characterization of two plant extracts, ethanolic lemongrass and 
aqueous (hot water) white tea, we chose to further test activity against lymphoma cell lines using an 
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Annexin-V binding assay. As previous results demonstrated with WST-1, both ETH-UF-LG and 
HW-WT were effective at inducing cell death by apoptosis in a dose-dependent manner in 3 
lymphoma cell lines as indicated by the presence of Annexin V and propidium iodide staining. 
Moreover, the lowest effective doses of LG (0.05 & 0.1 mg/mL) and WT (0.1 & 0.25mg/mL) were 
unable to induce cell death appreciably in a normal human fibroblast cell line which is a vital quality 
in developing selective chemotherapies. Surprisingly LG extract was also well tolerated in peripheral 
nucleated blood cells (PNBCs) whereas white tea induced apoptosis (of PNBCs) at higher doses. 
Despite this potential obstacle in the case of white tea, both extracts were well tolerated by mice 
when administered orally over a period of three weeks.  
The induction of apoptosis has been shown to be achieved by extrinsic and intrinsic 
mechanisms, both which converge towards the destabilization of the mitochondria. Indeed, we have 
demonstrated that both ETH-UF-LG and HW-WT cause mitochondrial dysfunction in a dose and 
time-dependent manner as seen by monitoring the mitochondrial membrane potential dissipation as 
shown in Figure 4A and a decrease in mitochondrial oxygen consumption relative to the control 
caused by these natural extracts (Figure 5B). The reduced oxygen consumption reflects dysfunctional 
complexes of electron transport chain. Interestingly, despite both natural extracts converging towards 
mitochondrial collapse and the induction of apoptosis, the initial requirement of the generation of 
ROS for cytotoxicity is extract-specific. HW-WT does not appreciably induce ROS in lymphoma and 
leukemia cells in contrast to ETF-UF-LG. ETH-UF-LG causes ROS generation and requires the 
generation of oxidative stress to yield mitochondrial membrane potential collapse and the cleavage of 
intrinsically and extrinsically related capases-8 and -9 leading to the subsequent execution of 
apoptosis. The initiation of both the intrinsic and extrinsic pathways have been associated with ROS 
production (Fulda, 2006) and these results offer further confirmation. Thus, it is plausible to propose 
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that several bioactive molecules found within ETH-UF-LG increase the production of ROS and/or 
decrease the antioxidant capacity of the cancer cells leading to the activation of apoptosis. 
4.2.3 Ramification of ROS Induced Apoptosis and Caspase Involvement  
 
ROS levels in cancer cells have been reported to be markedly higher in comparison to their 
normal counterparts. Through the stimulus of growth- competence genes and metabolic alterations, 
ROS can promote cell growth and proliferation, and may be a key factor in the abnormal rates of 
proliferation observed in cancer cells (Earnshaw, 1999). The exact mechanism of how this occurs is 
not clear, but it is hypothesized that these high levels of ROS are able to activate a variety of 
pathways related to a cellular stress mechanism. Consequently, this may lead to the ability of cancer 
cells to propagate more freely within their environment (Trottier, 2010). It is important to note that 
these high levels of ROS may in fact render cancer cells more sensitive to additional ROS production 
and can lead to apoptotic events (Manian, 2008). Indeed, our results have indicated that lemongrass 
extract treatment leads to the increased generation of ROS followed by cell death. Furthermore, the 
increase in the production of ROS is a critical step for the induction of apoptosis by lemongrass 
extract as pre-treatment with antioxidant N-acetylcysteine (NAC) blocked the induction of apoptosis. 
However, HW-WT was still able to cause cleavage of caspase-8, and double-stranded DNA breaks as 
indicated by positive staining for λ-H2AX independent of ROS generation, thus, illustrating how 
different natural extracts can yield apoptotic induction by different means (ROS vs. non-ROS 
mediated). 
The induction of apoptosis has been shown to be achieved by extrinsic and intrinsic 
mechanisms, both which converge towards the destabilization of the mitochondria. Indeed, we have 
demonstrated that both ETH-UF-LG and HW-WT cause mitochondrial dysfunction in a dose- and 
time-dependent manner as seen by monitoring the mitochondrial membrane potential dissipation and 
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a decrease in mitochondrial oxygen consumption relative to the control caused by these natural 
extracts. The reduced oxygen consumption reflects dysfunctional complexes of electron transport 
chain. Interestingly, despite both natural extracts converging towards mitochondrial collapse and the 
induction of apoptosis, the initial requirement of the generation of ROS for cytotoxicity is extract-
specific. HW-WT does not appreciably induce ROS in lymphoma and leukemia cells in contrast to 
ETF-UF-LG. ETH-UF-LG causes ROS generation and requires the generation of oxidative stress to 
yield mitochondrial membrane potential collapse and the cleavage of intrinsically and extrinsically 
related capases-8 and -9 leading to the subsequent execution of apoptosis. As previously mentioned, 
initiation of both the intrinsic and extrinsic pathways have been associated with ROS production and 
these results offer further confirmation. Thus, it is plausible to propose that several bioactive 
molecules found within ETH-UF-LG increase the production of ROS and/or decrease the antioxidant 
capacity of the cancer cells leading to the activation of apoptosis. Another important finding was 
highlighted when examining the effects of ETH-UF-LG and HW-WT against Jurkat cells lacking a 
functional Fas associated death domain (FADD) protein, which is involved in the activation of the 
extrinsic pathway of apoptosis (Green & Kroemer, 2004). WT was effective at inducing cell death by 
apoptosis in these dominant-negative FADD (dnFADD) Jurkat cells at both 0.1 and 0.25 mg/mL and 
was unable to produce ROS. This finding supports the previous results showing that the activity of 
WT is independent of producing oxidative stress for its cytotoxic activity and is independent of 
death-inducing signalling complex (DISC). On the contrary, LG was unable to induce appreciable 
cell death, but was still able to induce ROS generation, in the dnFADD Jurkat cells (Circu, 2010) . 
This suggests that ROS production is required before activation of proteins, such as caspase-8, for its 
apoptotic activity. As a whole, it is possible that the activation of caspase-8 by ROS via FADD 
protein could be the initial event required for the downstream apoptotic events to occur (e.g. 
mitochondrial collapse, activation of caspase-3), which warrants further characterization. Previous 
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work has demonstrated multiple roles that FADD protein may have in inflammatory or pro-death 
pathways via cell surface receptor activation (DeBerardinis, 2008). Therefore, ROS may be able to 
induce the activation of protein(s) involved in the recruitment of FADD to oligomerize, forming 
active DISCs. 
 
 Lymphoma Xenograft Model in Immunocompromised Mice 
 
Due to the activity of both ETH-UF-LG and HW-WT with their ability to induce cell death in 
various blood cancer cell lines, we wanted to explore the ability of these natural extracts to reduce 
xenograft tumors in nude mice.  A major drawback of natural extract treatments is their 
bioavailability and stability of the bioactive compounds (Fang, 2009). Furthermore, these treatments 
cannot be administered intravenously due to the potential for immune reactions from these complex 
mixtures of primary and secondary metabolites. Therefore, it is important to evaluate these natural 
extracts for their efficacy in reducing tumor growth when administered orally. Indeed, our results 
demonstrated that orally administered and supplemented drinking water with ETH-UF-LG and HW-
WT remarkably reduced tumor growth, decreased PCNA expression, and caused double-stranded 
DNA breaks in the tumors cells relative to the control. Interestingly, lemongrass extract has been 
shown to have inhibitory effect on carcinogen-induced colon cancer (Trachootham, 2009). 
Furthermore, there was no observable decrease in the activity of the mice as well as no effect on their 
weight profile during the course of treatment, indicating that these natural extracts are well tolerated. 
This illustrates the ability of these natural extracts to be effective not only in vitro, but in vivo as well. 
These results also indicate that the bioactive components of these extracts are absorbed and 
distributed to the tumor sites to affect tumor growth. 
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 Conclusions and Future Work 
 
The purpose of this thesis sought to investigate various natural health products as potential 
alternatives to current lymphoma therapies, providing both safe and efficacious properties. Of the 28 
original extracts, two standouts emerged - lemongrass and white tea – in which over the course of the 
study were further explored at the level of mechanistic action, selectivity, bioavailability and even 
tolerability in animal models. The results presented in this study are consistent with and help expand, to 
an extent, the scientific validation in existing literature. Moreover, it provides exciting support of the 
anecdotal evidence and reasoning behind many of the traditional uses including a safe pant based 
approach to treating disease. This could in turn provide lymphoma cancer patients with an additional 
option when considering treatment that is both viable as a standalone, in combination with other NHPs, 
or even as an adjunct to chemotherapy – under an oncologist/physician’s surveillance. Families of 
younger patients, such as children, may in fact be more keen on an alternative which is less taxing on a 
developing body. 
Future studies should aim to depict an even clearer understanding of cell death mechanisms in the 
context of these extracts as it relates to reactive oxygen species. Seemingly, there are some varying 
results with respect to how these multifaceted NHPs activate or inactivate specific pathways that 
ultimately however lead to the same end result- effective reduction of lymphoma cell viability and 
proliferation.  More experiments looking at the activation of the various caspases could be carried out 
by means of more western blotting and would have been done here had time not been of the essence. 
Personally, I think it would be interesting to see the activity of these NHPs using different extractions 
techniques that although deviate from the scope of “natural health” could prove to be quite useful in 
enhancing bioactivity while continuing to display low toxicity. With respect to lemongrass in specific, 
more standalone studies should be explored to gauge whether individual compounds are responsible for 
the promising results shown in this study or if all of the many different properties of a plant material 
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requires to be present in the same matrix. In our study, individual bioactive compounds did not appear 
to be affective in the treatment of lymphoma.  Lastly, it would be essential to replicate the animal study 
as not only was it cut short due to ethical reasons, a follow-up is crucial for scientifically validating the 
xenograft model. Several suggestions have been identified that would strengthen the conclusions of the 
in vivo work of this study. This would include evaluating both extracts for their efficacy as preventative 
therapy before introducing the animals to cancerous colonies. Moreover, extending the length and 
concentration of the extracts to access tolerability and whether toxicological issues arise if a max dose 
is surpassed. 
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